Clinical Trial

Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer)

Study acronym: BICOV
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2025 (before its estimated March 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
A multicenter, low-intervention, drug-based study to evaluate the feasibility and safety of a combined regimen of two intraperitoneal chemotherapy modalities (used in routine clinical practice) following interval surgery for the treatment of advanced ovarian cancer. This is an independent research project (free of commercial interests).
Trial Details
NCT Number NCT06902467
Lead Sponsor Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Conditions Ovarian Cancer
Enrollment 20 participants
Start Date 2023-02-27
Primary Completion 2026-03-15 (estimated)
Study Completion 2026-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-03-30